Search research articles
Contact Us
Filters
Showing results (51-60 of 133) with videos related to
Page
of 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 29, 2012
Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer
Christophe Massard, Isabelle Borget, Marie Cécile Le Deley, et al.
World Journal of Surgery
|
April 15, 2016
Anatomic Variability of the Upper Mediastinal Lymph Node Level VII
Dana M Hartl, Ingrid Breuskin, Haïtham Mirghani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 9, 2020
Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments
Séverine Coquerelle, Meryl Darlington, Morgane Michel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
July 15, 2024
Correction to: Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study
Pierre Gourdy, Patrice Darmon, Isabelle Borget, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
April 20, 2024
Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study
Pierre Gourdy, Patrice Darmon, Isabelle Borget, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 16, 2008
131I effective half-life and dosimetry in thyroid cancer patients
Hervé Remy, Isabelle Borget, Sophie Leboulleux, et al.
JCO Global Oncology
|
August 18, 2023
Organizational Impact of Immunotherapies in Advanced Cancers in France
Valentine Grumberg, Christos Chouaïd, Anne-Françoise Gaudin, et al.
Journal of Biomedical Informatics
|
December 26, 2015
Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting
Nicolas Martelli, Paul Hansen, Hélène van den Brink, et al.
Journal of Medical Economics
|
May 19, 2022
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France
Valentine Grumberg, Christos Chouaïd, François-Emery Cotté, et al.
Applied Health Economics and Health Policy
|
August 9, 2018
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates
Jaime Espin, Michael Schlander, Brian Godman, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 133) with videos related to
Sort By:
Page
of 14
European Journal of Cancer (Oxford, England : 1990)
|
February 29, 2012
Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer
Christophe Massard, Isabelle Borget, Marie Cécile Le Deley, et al.
World Journal of Surgery
|
April 15, 2016
Anatomic Variability of the Upper Mediastinal Lymph Node Level VII
Dana M Hartl, Ingrid Breuskin, Haïtham Mirghani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 9, 2020
Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments
Séverine Coquerelle, Meryl Darlington, Morgane Michel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
July 15, 2024
Correction to: Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study
Pierre Gourdy, Patrice Darmon, Isabelle Borget, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
April 20, 2024
Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study
Pierre Gourdy, Patrice Darmon, Isabelle Borget, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 16, 2008
131I effective half-life and dosimetry in thyroid cancer patients
Hervé Remy, Isabelle Borget, Sophie Leboulleux, et al.
JCO Global Oncology
|
August 18, 2023
Organizational Impact of Immunotherapies in Advanced Cancers in France
Valentine Grumberg, Christos Chouaïd, Anne-Françoise Gaudin, et al.
Journal of Biomedical Informatics
|
December 26, 2015
Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting
Nicolas Martelli, Paul Hansen, Hélène van den Brink, et al.
Journal of Medical Economics
|
May 19, 2022
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France
Valentine Grumberg, Christos Chouaïd, François-Emery Cotté, et al.
Applied Health Economics and Health Policy
|
August 9, 2018
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates
Jaime Espin, Michael Schlander, Brian Godman, et al.
Page
of 14